The FDA also granted Breakthrough Therapy Designation to Trodelvy (sacituzumab govitecan-hziy) for the treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC) whose disease has progressed on or after platinum-based chemotherapy
The battle of the prescription weight loss drugs continues
Recently, both the receptors have shown to heteromerize in vitro , eliciting synergistic signaling and -arrestin-2 recruitment (300)
In conclusion, although further studies are needed to verify the diagnostic and/ or predictive value of blood glutathione in heart failure as a part of a multi marker panel test, this study provides evidence that cardiac and systemic glutathione deficiency is related with the functional status and the structural cardiac abnormalities of patients with cardiac diseases
And unlike other GLP-1s, it works on just one chemical pathway, which can be harder on the body and may increase side effects like nausea and GI distress, says Dr
PMID: 38960516, DOI: 10.1016/j.jacc.2024.05.035